Prospective Randomized Trial of Iliohypogastric-ilioinguinal Nerve Block on Post-operative Morphine Use After Inpatient Surgery of the Female Reproductive Tract
Objective
To determine the impact of pre-operative and intra-operative ilioinguinal and iliohypogastric nerve block on post-operative analgesic utilization and length of stay (LOS). Methods: We conducted a prospective randomized double-blind placebo controlled trial to assess effectiveness of ilioinguinal-iliohypogastric nerve block (IINB) on post-operative morphine consumption in female study patients (n=60). Patients undergoing laparotomy via Pfannenstiel incision received injection of either 0.5% bupivacaine + 5mcg/ml epinephrine for IINB (Group I, n =28) or saline of equivalent volume given to the same site (Group II, n=32). All injections were placed before the skin incision and after closure of rectus fascia via direct infiltration. Measured outcomes were post-operative morphine consumption (and associated side-effects), visual analogue pain scores, and hospital length of stay (LOS). Results: No difference in morphine use was observed between the two groups (47.3mg in Group I vs. 45.9mg in Group II; p=0.85). There was a trend toward lower pain scores after surgery in Group I, but this was not statistically significant. The mean time to initiate oral narcotics was also similar, 23.3h in Group I and 22.8h in Group II (p=0.7). LOS was somewhat shorter in Group I compared to Group II, but this difference was not statistically significant (p=0.8). Side-effects occurred with similar frequency in both study groups. Conclusion: In this population of patients undergoing inpatient surgery of the female reproductive tract, utilization of post-operative narcotics was not significantly influenced by IINB. Pain scores and LOS were also apparently unaffected by IINB, indicating a need for additional properly controlled prospective studies to identify alternative methods to optimize post-surgical pain management and reduce LOS.
Journal of Negative Results in BioMedicine 2008Published: 28 November 2008
The complete article is available as a provisional PDF. The fully formatted PDF and HTML versions are in production.
Journal of Negative Results in BioMedicine 2008, 7:11doi:10.1186/1477-5751-7-11An Open Access Article
HP-hMG stimulation reduces OHSS risk in high responder patients
October 25th 2024A recent study found that highly purified human menotropin significantly lowers the risk of ovarian hyperstimulation syndrome compared to recombinant follicle stimulating hormone, highlighting the benefits of protocol individualization based on gonadotropin type.
Read More